Screening biomarkers for Sjogren’s Syndrome by computer analysis and evaluating the expression correlations with the levels of immune cells

BackgroundSjögren’s syndrome (SS) is a systemic autoimmune disease that affects about 0.04-0.1% of the general population. SS diagnosis depends on symptoms, clinical signs, autoimmune serology, and even invasive histopathological examination. This study explored biomarkers for SS diagnosis.MethodsWe...

Full description

Bibliographic Details
Main Authors: Yafang Zhong, Wei Zhang, Dongzhou Liu, Zhipeng Zeng, Shengyou Liao, Wanxia Cai, Jiayi Liu, Lian Li, Xiaoping Hong, Donge Tang, Yong Dai
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1023248/full
_version_ 1797805749011742720
author Yafang Zhong
Wei Zhang
Wei Zhang
Wei Zhang
Dongzhou Liu
Zhipeng Zeng
Shengyou Liao
Wanxia Cai
Jiayi Liu
Lian Li
Xiaoping Hong
Donge Tang
Yong Dai
author_facet Yafang Zhong
Wei Zhang
Wei Zhang
Wei Zhang
Dongzhou Liu
Zhipeng Zeng
Shengyou Liao
Wanxia Cai
Jiayi Liu
Lian Li
Xiaoping Hong
Donge Tang
Yong Dai
author_sort Yafang Zhong
collection DOAJ
description BackgroundSjögren’s syndrome (SS) is a systemic autoimmune disease that affects about 0.04-0.1% of the general population. SS diagnosis depends on symptoms, clinical signs, autoimmune serology, and even invasive histopathological examination. This study explored biomarkers for SS diagnosis.MethodsWe downloaded three datasets of SS patients’ and healthy pepole’s whole blood (GSE51092, GSE66795, and GSE140161) from the Gene Expression Omnibus (GEO) database. We used machine learning algorithm to mine possible diagnostic biomarkers for SS patients. Additionally, we assessed the biomarkers’ diagnostic value using the receiver operating characteristic (ROC) curve. Moreover, we confirmed the expression of the biomarkers through the reverse transcription quantitative polymerase chain reaction (RT-qPCR) using our own Chinese cohort. Eventually, the proportions of 22 immune cells in SS patients were calculated by CIBERSORT, and connections between the expression of the biomarkers and immune cell ratios were studied.ResultsWe obtained 43 DEGs that were mainly involved in immune-related pathways. Next, 11 candidate biomarkers were selected and validated by the validation cohort data set. Besides, the area under curves (AUC) of XAF1, STAT1, IFI27, HES4, TTC21A, and OTOF in the discovery and validation datasets were 0.903 and 0.877, respectively. Subsequently, eight genes, including HES4, IFI27, LY6E, OTOF, STAT1, TTC21A, XAF1, and ZCCHC2, were selected as prospective biomarkers and verified by RT-qPCR. Finally, we revealed the most relevant immune cells with the expression of HES4, IFI27, LY6E, OTOF, TTC21A, XAF1, and ZCCHC2.ConclusionIn this paper, we identified seven key biomarkers that have potential value for diagnosing Chinese SS patients.
first_indexed 2024-03-13T05:56:45Z
format Article
id doaj.art-448f0ec206cb4a9a8188bad10e9aa94c
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-13T05:56:45Z
publishDate 2023-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-448f0ec206cb4a9a8188bad10e9aa94c2023-06-13T04:31:47ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-06-011410.3389/fimmu.2023.10232481023248Screening biomarkers for Sjogren’s Syndrome by computer analysis and evaluating the expression correlations with the levels of immune cellsYafang Zhong0Wei Zhang1Wei Zhang2Wei Zhang3Dongzhou Liu4Zhipeng Zeng5Shengyou Liao6Wanxia Cai7Jiayi Liu8Lian Li9Xiaoping Hong10Donge Tang11Yong Dai12Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, ChinaClinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, ChinaSouth China Hospital, Health Science Center, Shenzhen University, Shenzhen, ChinaInnovative Markers Department, Fapon Biotech Inc., Dongguan, ChinaDepartment of Rheumatology and Immunology, Shenzhen People’s Hospital, The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, ChinaClinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, ChinaClinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, ChinaClinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, ChinaClinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, ChinaClinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, ChinaDepartment of Rheumatology and Immunology, Shenzhen People’s Hospital, The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, ChinaClinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, ChinaClinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, ChinaBackgroundSjögren’s syndrome (SS) is a systemic autoimmune disease that affects about 0.04-0.1% of the general population. SS diagnosis depends on symptoms, clinical signs, autoimmune serology, and even invasive histopathological examination. This study explored biomarkers for SS diagnosis.MethodsWe downloaded three datasets of SS patients’ and healthy pepole’s whole blood (GSE51092, GSE66795, and GSE140161) from the Gene Expression Omnibus (GEO) database. We used machine learning algorithm to mine possible diagnostic biomarkers for SS patients. Additionally, we assessed the biomarkers’ diagnostic value using the receiver operating characteristic (ROC) curve. Moreover, we confirmed the expression of the biomarkers through the reverse transcription quantitative polymerase chain reaction (RT-qPCR) using our own Chinese cohort. Eventually, the proportions of 22 immune cells in SS patients were calculated by CIBERSORT, and connections between the expression of the biomarkers and immune cell ratios were studied.ResultsWe obtained 43 DEGs that were mainly involved in immune-related pathways. Next, 11 candidate biomarkers were selected and validated by the validation cohort data set. Besides, the area under curves (AUC) of XAF1, STAT1, IFI27, HES4, TTC21A, and OTOF in the discovery and validation datasets were 0.903 and 0.877, respectively. Subsequently, eight genes, including HES4, IFI27, LY6E, OTOF, STAT1, TTC21A, XAF1, and ZCCHC2, were selected as prospective biomarkers and verified by RT-qPCR. Finally, we revealed the most relevant immune cells with the expression of HES4, IFI27, LY6E, OTOF, TTC21A, XAF1, and ZCCHC2.ConclusionIn this paper, we identified seven key biomarkers that have potential value for diagnosing Chinese SS patients.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1023248/fullSjogren’s Syndromemachine learningpotential biomarkerimmune cell disturbanceCIBERSORT
spellingShingle Yafang Zhong
Wei Zhang
Wei Zhang
Wei Zhang
Dongzhou Liu
Zhipeng Zeng
Shengyou Liao
Wanxia Cai
Jiayi Liu
Lian Li
Xiaoping Hong
Donge Tang
Yong Dai
Screening biomarkers for Sjogren’s Syndrome by computer analysis and evaluating the expression correlations with the levels of immune cells
Frontiers in Immunology
Sjogren’s Syndrome
machine learning
potential biomarker
immune cell disturbance
CIBERSORT
title Screening biomarkers for Sjogren’s Syndrome by computer analysis and evaluating the expression correlations with the levels of immune cells
title_full Screening biomarkers for Sjogren’s Syndrome by computer analysis and evaluating the expression correlations with the levels of immune cells
title_fullStr Screening biomarkers for Sjogren’s Syndrome by computer analysis and evaluating the expression correlations with the levels of immune cells
title_full_unstemmed Screening biomarkers for Sjogren’s Syndrome by computer analysis and evaluating the expression correlations with the levels of immune cells
title_short Screening biomarkers for Sjogren’s Syndrome by computer analysis and evaluating the expression correlations with the levels of immune cells
title_sort screening biomarkers for sjogren s syndrome by computer analysis and evaluating the expression correlations with the levels of immune cells
topic Sjogren’s Syndrome
machine learning
potential biomarker
immune cell disturbance
CIBERSORT
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1023248/full
work_keys_str_mv AT yafangzhong screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells
AT weizhang screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells
AT weizhang screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells
AT weizhang screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells
AT dongzhouliu screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells
AT zhipengzeng screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells
AT shengyouliao screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells
AT wanxiacai screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells
AT jiayiliu screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells
AT lianli screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells
AT xiaopinghong screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells
AT dongetang screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells
AT yongdai screeningbiomarkersforsjogrenssyndromebycomputeranalysisandevaluatingtheexpressioncorrelationswiththelevelsofimmunecells